DAPANORM L 10MG TABLET 10'S

How DAPANORM L 10MG TABLET 10'S Works

• DAPANORM L 10MG TABLET 10'S is a combination medication containing dapagliflozin and linagliptin, designed to manage blood sugar levels in adults with type 2 diabetes. It works through complementary mechanisms to improve glycemic control.
• Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, acts primarily in the kidneys. SGLT2 is responsible for reabsorbing glucose back into the bloodstream. By inhibiting SGLT2, dapagliflozin reduces the reabsorption of glucose, causing excess glucose to be excreted in the urine. This process lowers blood glucose levels and can also contribute to modest weight loss due to the caloric loss from the excreted glucose. The kidneys filter glucose from the blood, and SGLT2 inhibitors prevent the kidneys from reabsorbing this glucose back into the blood. The excess glucose is then eliminated through urine.
• Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the body's own ability to lower blood sugar. DPP-4 is an enzyme that inactivates incretin hormones, such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretin hormones are released in the gut in response to food intake and stimulate insulin release from the pancreas while suppressing glucagon secretion from the alpha cells of the pancreas. By inhibiting DPP-4, linagliptin increases the levels of active incretin hormones in the body. This leads to increased insulin secretion when blood sugar is high and decreased glucagon secretion, both of which help to lower blood sugar levels. Incretins help regulate glucose homeostasis by stimulating insulin release after meals and decreasing glucagon secretion. Linagliptin prolongs the action of incretin hormones, amplifying their beneficial effects on blood sugar control.
• The combination of dapagliflozin and linagliptin provides a dual approach to managing blood sugar. Dapagliflozin lowers blood sugar by increasing glucose excretion, while linagliptin enhances the body's natural mechanisms to regulate blood sugar by modulating insulin and glucagon levels. Together, they offer a more comprehensive approach to glycemic control compared to either medication used alone. This synergistic effect helps patients achieve and maintain target blood sugar levels more effectively. This combination helps in reducing the risk of cardiovascular events associated with type 2 diabetes and it is important to take DAPANORM L 10MG TABLET 10'S as prescribed by your healthcare provider, along with lifestyle modifications such as diet and exercise, to achieve the best possible outcomes in managing type 2 diabetes.

The following side effects may occur while taking DAPANORM L 10MG TABLET 10'S: **Common Side Effects:** * Hypoglycemia (low blood sugar), especially when used with other diabetes medications like sulfonylureas or insulin * Genital infections (both male and female) * Urinary tract infections (UTIs) * Increased urination * Thirst * Constipation * Nausea * Upper respiratory tract infections * Changes in cholesterol levels * Back pain * Dizziness **Uncommon Side Effects:** * Ketoacidosis (a serious condition with high levels of ketones in the blood or urine) * Kidney problems * Allergic reactions (rash, itching, swelling) * Increased risk of bone fractures * Necrotizing fasciitis of the perineum (Fournier's gangrene) - a rare but serious infection * Volume depletion (dehydration), leading to symptoms like lightheadedness or fainting * Increased hematocrit **Rare Side Effects:** * Severe allergic reactions (anaphylaxis) * Pancreatitis

• If you miss a dose of DAPANORM L 10MG TABLET 10'S, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for the missed one.

• Keep DAPANORM L 10MG TAB 1X10 away from the reach of children and pets.
• Store DAPANORM L 10MG TAB 1X10 at room temperature.

• **Take DAPANORM L 10MG as Prescribed:** Always adhere to your doctor's instructions regarding dosage and timing. Do not self-adjust the dose or discontinue the medication without consulting your healthcare provider, as this can lead to fluctuations in blood sugar levels.
• **Monitor Blood Sugar Regularly:** Regularly monitor your blood sugar levels as directed by your doctor. Keep a record of your readings to help track your response to DAPANORM L 10MG and share this information with your healthcare team. This is crucial for effective diabetes management.
• **Stay Hydrated and Maintain a Healthy Diet:** Drink plenty of water throughout the day to help your kidneys function properly. Follow a balanced diet that is low in processed foods, sugary drinks, and unhealthy fats. Focus on incorporating whole grains, lean proteins, fruits, and vegetables into your meals. A healthy diet supports optimal blood sugar control while on DAPANORM L 10MG.
• **Be Aware of Hypoglycemia Symptoms:** DAPANORM L 10MG can sometimes cause low blood sugar (hypoglycemia), especially when combined with other diabetes medications or if you skip meals. Be familiar with the symptoms of hypoglycemia, such as shakiness, sweating, dizziness, confusion, and rapid heartbeat. If you experience these symptoms, consume a fast-acting source of sugar, like glucose tablets or fruit juice, and contact your doctor immediately.
• **Inform Your Doctor About Other Medications and Medical Conditions:** Before starting DAPANORM L 10MG, inform your doctor about all other medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Also, disclose any existing medical conditions, particularly kidney or liver problems, heart conditions, or any history of allergic reactions. This information will help your doctor ensure that DAPANORM L 10MG is safe and appropriate for you.

• DAPANORM L 10MG TABLET 10'S can be taken with or without food. However, it is best to take it at a fixed time to maintain consistent blood sugar levels. Avoid excessive alcohol consumption while taking this medicine, as it may increase the risk of hypoglycemia (low blood sugar).